A four-arm randomized, double-blind trial compared oral CBD, THC, their combination, and placebo for peripheral neuropathic pain, providing rigorous head-to-head data on individual and combined cannabinoid effects.
Pain medicine clinicians, neurologists, neuropathic pain patients, and cannabis prescribers.
Four-arm double-blind trial: CBD vs. THC vs. combination vs. placebo for neuropathic pain
What the researchers found
The trial compared four conditions (CBD alone, THC alone, CBD/THC combination, and placebo) for neuropathic pain. Results provide controlled evidence on whether CBD, THC, or their combination offers meaningful pain relief in this population.
Why it matters
Cannabinoids are often prescribed for neuropathic pain despite weak evidence. This four-arm design directly compares individual cannabinoids, their combination, and placebo, providing the type of data clinical guidelines require.
The numbers in context
Four treatment arms with 1:1:1:1 randomization: CBD, THC, CBD/THC combination, and placebo. Oral capsule formulation for peripheral neuropathic pain.
How the study worked
Randomized, double-blind, placebo-controlled trial with four arms (1:1:1:1 ratio): CBD capsules, THC capsules, CBD/THC combination capsules, and placebo. Patients with peripheral neuropathic pain enrolled.
What this study cannot tell us
Oral capsules may produce different effects than smoked or vaporized cannabis. Specific doses tested may not reflect optimal dosing. Sample size determines the power to detect differences between arms. Duration of treatment may affect conclusions.
How to read the evidence
Randomized, double-blind, placebo-controlled trial with a robust four-arm design. High-quality evidence regardless of outcome direction.
When this study was published
Published 2023.
The bigger picture
Evidence-based guidelines currently give cannabinoids a "weak against" recommendation for neuropathic pain. Rigorous trials like this one either support or challenge that assessment and could shift clinical practice.
Questions still open
- Is the CBD/THC combination more effective than either alone? Does the route of administration (oral vs. inhaled) significantly affect neuropathic pain outcomes?
Common questions
Does cannabis help neuropathic pain?
Is THC or CBD better for nerve pain?
Read the original research
Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment.
European journal of pain (London, England), 27(4), 492-506
Citation
Zubcevic, Kanita; Petersen, Merete; Bach, Flemming Winther; Heinesen, Aksel; Enggaard, Thomas Peter; Almdal, Thomas Peter; Holbech, Jakob Vormstrup; Vase, Lene; Jensen, Troels Stahelin; Hansen, Christian Stevns; Finnerup, Nanna Brix; Sindrup, Søren H. (2023). Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment.. European journal of pain (London, England), 27(4), 492-506. https://doi.org/10.1002/ejp.2072
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk